Published: Oct 18th, 2015
UFDI investigators and collaborators found that granulocyte colony stimulating factor monotherapy did not affect C-peptide production, HbA1c, or insulin dose.This study supports the continued exploration of G-CSF and other mobilizing […]
Published: Jun 21st, 2014
UF and UF Health faculty, postdoctoral fellows, and graduate students submitted a record number of original research presentations for the American Diabetes Association’s 74th Scientific Sessions held June 13-17, 2014 at the Moscone Center in San Francisco, California. This year’s submissions represent one of the largest showcases of research emanating from UF.
Published: May 8th, 2014
Diabetes investigators at UF Health are seeking participants for a pharmaceutical research study of 1 and up to 3 years to test an investigational new drug for the treatment of Type 1 diabetes. We are looking for males and females between the ages of 18 and 35 who have been diagnosed with Type 1 diabetes within the past 8 weeks. Enrolled participants will receive payment compensation for their time and travel during the study. Learn more.
Published: Apr 30th, 2009
Note: This study is no longer recruiting new participants. Study Name: Cord Blood Combination with Vitamin D and Omega-3 Principal Investigator: Michael J. Haller, M.D. Study Coordinator: Miriam Cintron Phone: […]